Dual drug nanoparticle synergistically induced apoptosis, suppressed inflammation, and protected autophagic response in rheumatoid arthritis fibroblast-like synoviocytes

• Published in: Immunology letters 2024-06, Vol.267, p.106854-106854, Article 106854
• Main Authors: Haloi, Prakash, Choudhary, Rajat, Lokesh, B. Siva, Konkimalla, V. Badireenath
• Format: Article
• Language: English
• Subjects: Apoptosis; Fibroblast-like synoviocytes; Methotrexate; Phenethyl isothiocyanate; Rheumatoid arthritis
• ISSN: 0165-2478; 1879-0542
• DOI: 10.1016/j.imlet.2024.106854

•Dual drug nanoparticle hydrogel of MTX and PEITC (DD NP HG) was biocompatible to healthy FLS.•DD NP HG exerts a synergistic anti-inflammatory effect in LPS-stimulated RA-FLS.•The combination approach of PEITC and MTX (DD NP HG) effectively promoted bone remodeling in LPS-stimulated RA-FLS.•DD NP HG-induced apoptosis protected RA-FLS from undergoing autophagy. Rheumatoid arthritis (RA) is a chronic immune-mediated joint inflammatory disorder associated with aberrant activation of fibroblast-like synoviocytes (FLS). Recently, FLS gained importance due to its crucial role in RA pathogenesis, and thus, targeting FLS is suggested as an attractive treatment strategy for RA. FLS-targeted approaches may be combined with disease-modifying antirheumatic drugs (DMARDs) and natural phytochemicals to improve efficacy in RA control and negate immunosuppression. In this study, we assessed the therapeutic effectiveness of DD NP HG in primary RA-FLS cells isolated from the synovial tissue of FCA-induced RA rats. We observed that DD NP HG had good biosafety for healthy FLS cells and, at higher concentrations, a mild inhibitory effect on RA-FLS. The combination therapy (DD NP HG) of MTX NP and PEITC NE in RA-FLS showed a higher rate of apoptosis with significantly reduced LPS-induced expression of pro-inflammatory cytokines (TNF-α, IL-17A, and IL-6) in arthritic FLS. Further, the gene expression studies showed that DD NP HG significantly down-regulated the mRNA expression of IL-1β, RANKL, NFATc1, DKK1, Bcl-xl, Mcl-1, Atg12, and ULK1, and up-regulated the mRNA expression of OPG, PUMA, NOXA and SQSTM1 in LPS-stimulated RA-FLS cells. Collectively, our results demonstrated that DD NP HG significantly inhibited the RA-FLS proliferation via inducing apoptosis, down-regulating pro-inflammatory cytokines, and further enhancing the expression of genes associated with bone destruction in RA pathogenesis. A nanotechnology approach is a promising strategy for the co-delivery of dual drugs to regulate the RA-FLS function and achieve synergistic treatment of RA. [Display omitted]